UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Oncogene, 2015-04, Vol.34 (16), p.2138-2144

2015

Volltextzugriff (PDF)

Immune Reconstitution Inflammatory Syndrome Associated With Kaposi's Sarcoma

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5224-5228

2005

Volltextzugriff (PDF)

A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions

Annals of oncology, 2022-11, Vol.33 (11), p.1202-1204

2022

Volltextzugriff (PDF)

The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases

Supportive care in cancer, 2019-04, Vol.27 (4), p.1255-1261

2019

Volltextzugriff (PDF)

79: Real-world use of checkpoint inhibitors in the management of thoracic malignancies: a single-institution experience

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S37-S37

2017

Volltextzugriff (PDF)

103: Independent prescribing pharmacist clinics; how they can benefit oncology services

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S46-S47

2017

Volltextzugriff (PDF)

Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression

Annals of oncology, 2012-01, Vol.23 (1), p.141-147

2012

Volltextzugriff (PDF)

Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?

British journal of cancer, 2003-08, Vol.89 (3), p.457-459

2003

Volltextzugriff (PDF)

Functional immune characterization of HIV-associated non-small-cell lung cancer

Annals of oncology, 2018-06, Vol.29 (6), p.1486-1488

2018

Volltextzugriff (PDF)

Brigatinib experience on the ALK project

Annals of oncology, 2019-04, Vol.30, p.ii53-ii53

2019

Volltextzugriff (PDF)

Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy

HIV medicine, 2006-07, Vol.7 (5), p.291-293

2006

Volltextzugriff (PDF)

110: Drug interactions with systemic anti-cancer therapy in lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S49-S50

2017

Volltextzugriff (PDF)

109: Characteristics of HIV-associated lung cancer

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S49-S49

2017

Volltextzugriff (PDF)

86: The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S40-S41

2017

Volltextzugriff (PDF)

87: Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S41-S41

2017

Volltextzugriff (PDF)

3092 Systemic immune-inflammation index (SII) in patients with advanced non-small cell lung cancer (nsclc)

European journal of cancer (1990), 2015-09, Vol.51, p.S630-S630

2015

Volltextzugriff (PDF)

42 Lung cancer diagnosis in the acute setting

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S16-S16

2014

Volltextzugriff (PDF)

95 Impact of lung cancer acute oncology admissions in London

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S35-S36

2014

Volltextzugriff (PDF)

23 Characteristics of lung cancer patients diagnosed following emergency admission

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S8-S9

2016

Volltextzugriff (PDF)

69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S32-S33

2017

Volltextzugriff (PDF)

FRI0009 CD4+ T helper cells in rheumatoid arthritis express high levels of interleukin-21

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.313-313

2013

Volltextzugriff (PDF)

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S28-S29

2017

Volltextzugriff (PDF)

31 Histolopathological trends in HIV-associated lung cancer

Lung cancer (Amsterdam, Netherlands), 2011, Vol.71, p.S11-S11

2011

Volltextzugriff (PDF)

Voodoo dolls and the cancer patient: patients do trust their doctors

QJM : An International Journal of Medicine, 2009-05, Vol.102 (5), p.311-319

2009

Volltextzugriff (PDF)

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

The New England journal of medicine, 2017-02, Vol.376 (7), p.629-640

2017

Volltextzugriff (PDF)

1 – 25 von 754

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(713)
Mit Volltextzugriff
(636)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(386)
Science & Technology
(344)
Life Sciences & Biomedicine
(331)
Male
(178)
Female
(176)
Biological And Medical Sciences
(165)
Adult
(163)
Neurosciences & Neurology
(159)
Medical Sciences
(149)
Middle Aged
(138)
Neurology
(130)
Clinical Neurology
(129)
Myasthenia Gravis - Immunology
(109)
Neurosciences
(94)
Receptors, Cholinergic - Immunology
(92)
Animals
(89)
Aged
(88)
Diseases Of Striated Muscles. Neuromuscular Diseases
(86)
Immunology
(69)
Adolescent
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of The New York Academy Of Sciences
(86)
Lung Cancer
(44)
Journal Of Neuroimmunology
(41)
The Lancet
(40)
Neurology
(37)
Brain
(36)
Annals Of Neurology
(27)
Journal Of Neurology, Neurosurgery And Psychiatry
(27)
Annals Of Oncology
(23)
Journal Of Autoimmunity
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Immune Reconstitution Inflammatory Syndrome Associated With Kaposi's Sarcoma

A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions

The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases

79: Real-world use of checkpoint inhibitors in the management of thoracic malignancies: a single-institution experience

103: Independent prescribing pharmacist clinics; how they can benefit oncology services

Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression

Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?

Functional immune characterization of HIV-associated non-small-cell lung cancer

Brigatinib experience on the ALK project

Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy

110: Drug interactions with systemic anti-cancer therapy in lung cancer patients

109: Characteristics of HIV-associated lung cancer

86: The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

87: Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS

3092 Systemic immune-inflammation index (SII) in patients with advanced non-small cell lung cancer (nsclc)

42 Lung cancer diagnosis in the acute setting

95 Impact of lung cancer acute oncology admissions in London

23 Characteristics of lung cancer patients diagnosed following emergency admission

69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme

FRI0009 CD4+ T helper cells in rheumatoid arthritis express high levels of interleukin-21

62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

31 Histolopathological trends in HIV-associated lung cancer

Voodoo dolls and the cancer patient: patients do trust their doctors

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

Suchergebnisse filtern